Background: Non-alcoholic fatty liver disease is an obesity-related chronic liver disorder ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), which may progress to liver fibrosis and cirrhosis. Objective: Tto investigate the role of Toll-like receptor (TLR) 4 in mediating the transition from steatosis to inflammation. Methods: ApoE -/-/TLR4 mut mice and ApoE -/-/TLR4 wild-type mice (ApoE -/-/TLR4-WT) were generated by cross-breeding an ApoE-deficient (ApoE -/-) strain with TLR4-mutant (TLR4 mut) mice, which were fed with high-fat, high-cholesterol (HFHC) diet to induce obesity. Results: ApoE -/-/TLR4-WT mice fed with an HFHC diet for 12 weeks developed typical pathological features of NASH, which is associated with obesi...
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
BACKGROUND and AIMS: Inflammation promotes the progression of non-alcoholic steatohepatitis (NASH). ...
Background & Aims: Innate immune dysfunction can promote chronic inflammatory diseases of the liver....
Category: Integrated Physiology - Liver: abstract no. 1655-PRESULTS: Nonalcoholic steatohepatitis (N...
Toll-like receptors (TLR) recognize pathogen-derived molecules and induce downstream activation of i...
Abstract Background Previously we reported that mice deficient in toll-like receptor 4 (TLR-4) signa...
Background and aim. The etiology of non-alcoholic fatty liver disease (NAFLD) progression, and why s...
Background and aims: TLR9 deletion protects against steatohepatitis due to choline-amino acid deplet...
Chronic low-grade inflammation is a hallmark of obesity and thought to contribute to the development...
Background: Increasing evidence suggests that innate immunity is involved in the development of nona...
Toll-like receptor 4 (TLR4), and its co-receptor, Myeloid Differentiation Factor 2 (MD-2), are key i...
Background & Aims: Toll-like receptor 4 (TLR4) signaling is activated through 2 adaptor proteins: My...
Activation of innate immunity is associated with the development of liver disease, including non-alc...
Objective: Recent studies have suggested a critical role for toll-like receptor 4 (TLR4) in the deve...
Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammatio...
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
BACKGROUND and AIMS: Inflammation promotes the progression of non-alcoholic steatohepatitis (NASH). ...
Background & Aims: Innate immune dysfunction can promote chronic inflammatory diseases of the liver....
Category: Integrated Physiology - Liver: abstract no. 1655-PRESULTS: Nonalcoholic steatohepatitis (N...
Toll-like receptors (TLR) recognize pathogen-derived molecules and induce downstream activation of i...
Abstract Background Previously we reported that mice deficient in toll-like receptor 4 (TLR-4) signa...
Background and aim. The etiology of non-alcoholic fatty liver disease (NAFLD) progression, and why s...
Background and aims: TLR9 deletion protects against steatohepatitis due to choline-amino acid deplet...
Chronic low-grade inflammation is a hallmark of obesity and thought to contribute to the development...
Background: Increasing evidence suggests that innate immunity is involved in the development of nona...
Toll-like receptor 4 (TLR4), and its co-receptor, Myeloid Differentiation Factor 2 (MD-2), are key i...
Background & Aims: Toll-like receptor 4 (TLR4) signaling is activated through 2 adaptor proteins: My...
Activation of innate immunity is associated with the development of liver disease, including non-alc...
Objective: Recent studies have suggested a critical role for toll-like receptor 4 (TLR4) in the deve...
Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammatio...
BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fu...
BACKGROUND and AIMS: Inflammation promotes the progression of non-alcoholic steatohepatitis (NASH). ...
Background & Aims: Innate immune dysfunction can promote chronic inflammatory diseases of the liver....